11 results
Total Anomalous Pulmonary Venous Return (TAPVR)
 • Introduction
 • Classification
 • Pathophysiology of TAPVR
 • Presentation
Introduction • Classification ... • Pathophysiology ... supracardiac TAPVR • Pre-Operative ... cardiology #peds #pediatrics ... #summary
Esophageal Variceal Bleeding - Scoping Summary
GENERAL PRINCIPLES OF MANAGEMENT (VARICEAL-B):
V - Vasoconstrictor therapy: (Octreotide 50mcg bolus
- Scoping Summary ... , consider for active ... acute settings - Pre-endoscopic ... #Summary #Endoscopy ... diagnosis #management #algorithm
Summary table of types of hypersensitivity reactions. 
Type 1
 - Mediators: lgE
 - Antigen Form: Soluble
Summary table of ... cell antigens, leading ... Antigen-antibody complexes are ... tissues where they activate ... allergy #table #classification
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
and Management Summary ... signs/symptoms of active ... pulmonary TB PE ... decreased reflexes Pathophysiology ... excisional biopsy - Detection
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology Summary ... Vaughan Williams Classification ... node and AV node activity ... #Pharmacology #Classification ... #Classes #pathophysiology
Hypersensitivity Types and Their Mechanisms
Type I - lgE - Soluble antigen
 - Allergen-specific lgE antibodies bind
cellular antigen, leading ... Antigen-antibody complexes are ... cytokines, which activate ... Hypersensitivity #Types #Classification ... #Pathophysiology
Cryoglobulinemia Summary

Cryoglobulins:
 • Cryoglobulins are Igs in the serum that precipitate in vitro at temperatures below
Cryoglobulinemia Summary ... • They can activate ... immune system, leading ... rheumatoid factor activity ... diagnosis #types #classification
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... terminal alveoli and are ... inhibitors • Injection ... involvement - seeding ... Langerhans giant cells are
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... terminal alveoli and are ... inhibitors • Injection ... involvement - seeding ... Langerhans giant cells are
Pheochromocytoma - Diagnosis and Management Summary
10 percent rule = 10% of pheochromocytomas are extra-adrenal, multiple, bilateral,
and Management Summary ... bilateral, malignant, pediatric ... laparoscopic tumor resection ... Open surgical resection ... adrenoceptors, potentially leading